A Bibliometric Analysis in Gene Research of Myocardial Infarction from 2001 to 2015
Overview
Environmental Health
General Medicine
Affiliations
Objectives: We aimed to evaluate the global scientific output of gene research of myocardial infarction and explore their hotspots and frontiers from 2001 to 2015, using bibliometric methods.
Methods: Articles about the gene research of myocardial infarction between 2001 and 2015 were retrieved from the Web of Science Core Collection (WoSCC). We used the bibliometric method and Citespace V to analyze publication years, journals, countries, institutions, research areas, authors, research hotspots, and trends. We plotted the reference co-citation network, and we used key words to analyze the research hotspots and trends.
Results: We identified 1,853 publications on gene research of myocardial research from 2001 to 2015, and the annual publication number increased with time. Circulation published the highest number of articles. United States ranked highest in the countries with most publications, and the leading institute was Harvard University. Relevant publications were mainly in the field of Cardiovascular system cardiology. Keywords and references analysis indicated that gene expression, microRNA and young women were the research hotspots, whereas stem cell, chemokine, inflammation and cardiac repair were the frontiers.
Conclusions: We depicted gene research of myocardial infarction overall by bibliometric analysis. Mesenchymal stem cells Therapy, MSCs-derived microRNA and genetic modified MSCs are the latest research frontiers. Related studies may pioneer the future direction of this filed in next few years. Further studies are needed.
Chen Y, Shen P, He Y, Zeng D, Li Y, Zhang Y Acta Neurochir (Wien). 2024; 166(1):307.
PMID: 39060813 DOI: 10.1007/s00701-024-06204-w.
Cetira Filho E, Granville-Garcia A, Silva Junior J, Maferano E, Barros Silva P, Costa F Oral Maxillofac Surg. 2024; 28(3):1105-1115.
PMID: 38910211 DOI: 10.1007/s10006-024-01274-7.
Peng Y, Wang T, Wang J, Wang H, Fan R, Gong L Endocr Metab Immune Disord Drug Targets. 2024; 24(11):1280-1290.
PMID: 38178659 DOI: 10.2174/0118715303264254231117113456.
Hu L, Yang J, Liu T, Zhang J, Huang X, Yu H J Pain Res. 2023; 16:3673-3691.
PMID: 37942222 PMC: 10629439. DOI: 10.2147/JPR.S422614.
Zhang J, Liu L, Zhu M, Zheng X, Liang Y, Zhong Y J Pain Res. 2023; 16:2189-2204.
PMID: 37397275 PMC: 10314771. DOI: 10.2147/JPR.S415998.